Technical / White Paper
Data Mining At The FDA
The FDA has recommended the use of data mining to the drug industry, and their new Data Mining at FDA white paper summarizes their past and current data mining activities, and addresses data miners in all sectors.
Oracle Health Sciences Consulting’s Dr. Sameer Thapar has studied this paper and offers highlights in a new Oracle Brief. Download now to learn more about how the FDA uses Oracle Health Sciences safety solutions to analyze clinical trial data in New Drug Applications or supplemental applications, and for routine mining of drugs, foods, cosmetics, and dietary supplements.